Evonile Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹56 crore and a net loss of ₹78 crore for the September 2026 quarter.
Evonile Pharma (NSE: EVONILE) closed at ₹1,367.60 on 20 Nov 2026. Its market capitalisation is ₹4,784 crore and it trades at 74.4 times earnings.
Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods. It imports various medicines to India from different sources across the globe.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.